Clinical Trial Update: OSU6162 in Bipolar Depression (OBID) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating OSU6162 for bipolar depression is currently recruiting, sponsored by Göteborg University under the OBID program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• OSU6162 (OSU6162)

Snippet

Sponsor: Göteborg University | Conditions: Bipolar Depression | Phase 2 | Status: RECRUITING